111 related articles for article (PubMed ID: 21103624)
1. Molecular profiling of ADAM12 gene in breast cancers.
Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
Narita D; Seclaman E; Ursoniu S; Anghel A
Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
[TBL] [Abstract][Full Text] [Related]
3. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.
Cireap N; Narita D
Pathol Oncol Res; 2013 Oct; 19(4):755-62. PubMed ID: 23645517
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.
Li H; Duhachek-Muggy S; Dubnicka S; Zolkiewska A
Breast Cancer Res Treat; 2013 Jun; 139(3):691-703. PubMed ID: 23771733
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of ADAM12 in human bladder cancer.
Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.
Ma B; Ma Q; Jin C; Wang X; Zhang G; Zhang H; Seeger H; Mueck AO
Int J Clin Exp Pathol; 2015; 8(10):13279-83. PubMed ID: 26722530
[TBL] [Abstract][Full Text] [Related]
8. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
9. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
Aghababaei M; Perdu S; Irvine K; Beristain AG
Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
Stautz D; Wewer UM; Kveiborg M
PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
[TBL] [Abstract][Full Text] [Related]
12. An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.
Li H; Duhachek-Muggy S; Qi Y; Hong Y; Behbod F; Zolkiewska A
Breast Cancer Res Treat; 2012 Oct; 135(3):759-69. PubMed ID: 22926263
[TBL] [Abstract][Full Text] [Related]
13. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling.
Le Pabic H; Bonnier D; Wewer UM; Coutand A; Musso O; Baffet G; Clément B; Théret N
Hepatology; 2003 May; 37(5):1056-66. PubMed ID: 12717386
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12.
Xiong L; Yan W; Zubia E; Zhou Y; Zhang Y; Duan Q; Narayan M; Xu G
J Proteomics; 2018 Jun; 182():34-44. PubMed ID: 29729432
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and expression analysis of ADAM12 during chicken embryonic development.
Lin J; Luo J; Redies C
Dev Growth Differ; 2010 Dec; 52(9):757-69. PubMed ID: 21158755
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
Dyczynska E; Syta E; Sun D; Zolkiewska A
Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
[TBL] [Abstract][Full Text] [Related]
17. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
[TBL] [Abstract][Full Text] [Related]
19. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth.
Albrechtsen R; Kveiborg M; Stautz D; Vikeså J; Noer JB; Kotzsh A; Nielsen FC; Wewer UM; Fröhlich C
J Cell Sci; 2013 Oct; 126(Pt 20):4707-20. PubMed ID: 24006261
[TBL] [Abstract][Full Text] [Related]
20. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.
Fröhlich C; Nehammer C; Albrechtsen R; Kronqvist P; Kveiborg M; Sehara-Fujisawa A; Mercurio AM; Wewer UM
Mol Cancer Res; 2011 Nov; 9(11):1449-61. PubMed ID: 21875931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
